Orchestra BioMed Holdings Target Price

See Orchestra BioMed Holdings's analyst price targets ($12) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.08

Average Target Price

$11.50

126.4% upside

2 analysts in the last 4 months

High: $13 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-11	Piper SandlerMatt O'Brien	$10	96.9% upside
2026-05-13	BarclaysMatt Miksic	$13	155.9% upside
2026-01-09	BarclaysMatt Miksic	$12	136.2% upside
2025-03-20	BTIGMarie Thibault	$12	136.2% upside

Orchestra BioMed Holdings (OBIO) FAQ

As of the most recent data, OBIO shows a target price of $12. Scroll down for historical charts and peer comparison views.

If Orchestra BioMed Holdings moved to the average analyst target of $12, shares would be roughly 126.4% higher than $5.08. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Orchestra BioMed Holdings's earnings trajectory.

Besides this target price page, Stockcircle has Orchestra BioMed Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $12) with ownership activity and broader fundamentals.